Clinical Trials
2 trialsNCT06877533 2025-08-12
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
iTeos Therapeutics
Phase 1 Terminated
NCT03777930 2018-12-19
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol
Shenzhen Fifth People's Hospital
Phase 4 Unknown